David Mark McClung

Insider Reports History

Entity
Individual
Location
7000 Marina Blvd, Brisbane, CA
Signature
David Mark McClung, by /s/ Ron A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Mark McClung:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SANGAMO THERAPEUTICS, INC EVP, Chief Operating Officer Common Stock 212K $81.2K $0.38 Nov 25, 2023 Direct

Insider Reports Filed by David Mark McClung

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGMO SANGAMO THERAPEUTICS, INC Nov 25, 2023 1 -$736 4 Nov 28, 2023 EVP, Chief Operating Officer
SGMO SANGAMO THERAPEUTICS, INC Aug 25, 2023 1 -$1.48K 4 Aug 29, 2023 EVP, Chief Operating Officer
SGMO SANGAMO THERAPEUTICS, INC Jun 25, 2023 1 -$13.7K 4 Jun 26, 2023 EVP, Chief Operating Officer
SGMO SANGAMO THERAPEUTICS, INC May 25, 2023 1 -$2.56K 4 May 30, 2023 EVP, Chief Operating Officer
SGMO SANGAMO THERAPEUTICS, INC Feb 24, 2023 3 -$25.9K 4 Mar 6, 2023 EVP, Chief Operating Officer
SGMO SANGAMO THERAPEUTICS, INC Jun 25, 2022 1 -$49.7K 4 Jun 28, 2022 EVP, Chief Operating Officer
SGMO SANGAMO THERAPEUTICS, INC Feb 25, 2022 3 -$27.2K 4 Mar 1, 2022 EVP, Chief Operating Officer
SGMO SANGAMO THERAPEUTICS, INC Jun 25, 2021 1 -$139K 4 Jun 29, 2021 EVP, Chief Business Officer